{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:14:42Z","timestamp":1787962482064,"version":"build-2784847793"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","award":["28-A-14"],"award-info":[{"award-number":["28-A-14"]}],"id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17ck0106210h0002"],"award-info":[{"award-number":["17ck0106210h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015322","name":"National Cancer Center Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15H05675"],"award-info":[{"award-number":["15H05675"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001960","name":"American Society for Radiation Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001960","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ijrobp.2021.03.049","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T11:48:50Z","timestamp":1617191330000},"page":"117-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["A Phase 2 Study of Image-Guided Proton Therapy for Operable or Ablation-Treatable Primary Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"111","author":[{"given":"Hiromitsu","family":"Iwata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ogino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kento","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Toshito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-etsu","family":"Mizoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Shibamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2021.03.049_bib0001","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: Results from the global burden of disease study 2015","volume":"3","author":"Akinyemiju","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-981-10-8684-7_2","article-title":"Epidemiology and etiologic associations of non-alcoholic fatty liver disease and associated HCC","volume":"1061","author":"Liu","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0003","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/hepr.13438","article-title":"Report of the 20th nationwide follow-up survey of primary liver cancer in Japan","volume":"50","author":"Kudo","year":"2020","journal-title":"Hepatol Res"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0004","doi-asserted-by":"crossref","first-page":"779","DOI":"10.9738\/INTSURG-D-13-00122.1","article-title":"Current and future challenges in the surgical treatment of hepatocellular carcinoma: A review","volume":"99","author":"Tsoulfas","year":"2014","journal-title":"Int Surg"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jhep.2012.09.020","article-title":"Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: Analysis of prognostic factors","volume":"58","author":"Kim","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0006","doi-asserted-by":"crossref","first-page":"S4002","DOI":"10.1200\/JCO.2019.37.15_suppl.4002","article-title":"A multicenter randomized controlled trial to evaluate the efficacy of surgery vs. radiofrequency ablation for small hepatocellular carcinoma (SURF trial)","volume":"37","author":"Izumi","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0007","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jhep.2012.05.007","article-title":"A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma","volume":"57","author":"Feng","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0008","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/0284186X.2013.820342","article-title":"Stereotactic body radiotherapy for small hepatocellular carcinoma: A retrospective outcome analysis in 185 patients","volume":"53","author":"Sanuki","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0009","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijrobp.2019.12.004","article-title":"Curative irradiation treatment of hepatocellular carcinoma: A multicenter phase 2 trial","volume":"107","author":"Durand-Labrunie","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0010","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1002\/cncr.26134","article-title":"Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma","volume":"117","author":"Komatsu","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0011","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.radonc.2018.10.041","article-title":"Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma","volume":"133","author":"Chadha","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0012","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.radonc.2014.08.015","article-title":"Association between pretreatment retention rate of indocyanine green 15 min after administration and life prognosis in patients with HCC treated by proton beam therapy","volume":"113","author":"Mizumoto","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0013","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1872-034X.2010.00731.x","article-title":"Report of the 18th follow-up survey of primary liver cancer in Japan","volume":"40","author":"Ikai","year":"2010","journal-title":"Hepatol Res"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0014","doi-asserted-by":"crossref","unstructured":"Iwata H, Ogino H, Hashimoto S, et\u00a0al. Spot scanning and passive scattering proton therapy: relative biological effectiveness and oxygen enhancement ratio in cultured cells. Int J Radiat Oncol Biol Phys 2016;95:95-102.","DOI":"10.1016\/j.ijrobp.2016.01.017"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0015","doi-asserted-by":"crossref","unstructured":"Toshito T, Omachi C, Kibe Y, et\u00a0al. A proton therapy system in Nagoya Proton Therapy Center. Australas Phys Eng Sci Med 2016;39:645-654.","DOI":"10.1007\/s13246-016-0456-8"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0016","doi-asserted-by":"crossref","unstructured":"Nakajima K, Iwata H, Ogino H, et\u00a0al. Clinical outcomes of image-guided proton therapy for histologically confirmed Stage I non-small cell lung cancer. Radiat Oncol 2018;13:199.","DOI":"10.1186\/s13014-018-1144-5"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0017","doi-asserted-by":"crossref","unstructured":"Ohta K, Shimohira M, Sasaki S, et\u00a0al. Transarterial fiducial marker placement for image-guided proton therapy for malignant liver tumors. Cardiovasc Intervent Radiol 2015;38:1288-1293.","DOI":"10.1007\/s00270-014-1013-z"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0018","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0360-3016(00)01555-8","article-title":"Methodologies and tools for proton beam design for lung tumors","volume":"49","author":"Moyers","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0019","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0020","doi-asserted-by":"crossref","unstructured":"Shibamoto Y, Miyakawa A, Otsuka S, Iwata H. Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules? J Radiat Res 2016;57:i76-i82.","DOI":"10.1093\/jrr\/rrw015"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0021","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.1840210515","article-title":"Calculation of child and adult standard liver volume for liver transplantation","volume":"21","author":"Urata","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0022","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.2015.64.2710","article-title":"Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"34","author":"Hong","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0023","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/cas.13145","article-title":"Long-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma","volume":"108","author":"Fukuda","year":"2017","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0024","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/cncr.32502","article-title":"A phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma: safety and efficacy","volume":"126","author":"Jang","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0025","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/jgh.12350","article-title":"Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma","volume":"29","author":"Takeda","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0026","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ijrobp.2013.10.045","article-title":"Threshold doses for focal liver reaction after stereotactic ablative body radiation therapy for small hepatocellular carcinoma depend on liver function: evaluation on magnetic resonance imaging with Gd-EOB-DTPA","volume":"88","author":"Sanuki","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167155","article-title":"Evaluation of focal liver reaction after proton beam therapy for hepatocellular carcinoma examined using Gd-EOB-DTPA enhanced hepatic magnetic resonance imaging","volume":"11","author":"Takamatsu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0028","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijrobp.2019.02.032","article-title":"Predictors of radiation-induced liver disease in Eastern and Western patients with hepatocellular carcinoma undergoing proton beam therapy","volume":"105","author":"Hsieh","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0029","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1748-717X-8-48","article-title":"What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy","volume":"8","author":"Toramatsu","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0030","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ijrobp.2020.04.027","article-title":"Dosimetric analysis and normal-tissue complication probability modeling of Child-Pugh score and albumin-bilirubin grade increase after hepatic irradiation","volume":"107","author":"Pursley","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0031","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.radonc.2017.03.004","article-title":"Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma","volume":"123","author":"Oshiro","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0032","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.18632\/oncotarget.23428","article-title":"Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma","volume":"9","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0033","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/liv.14087","article-title":"Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis","volume":"39","author":"Bengtsson","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0034","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.adro.2019.05.002","article-title":"First-in-human phase 1 study of a nonwoven fabric bioabsorbable spacer for particle therapy: Space-making particle therapy (SMPT)","volume":"4","author":"Sasaki","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0035","doi-asserted-by":"crossref","first-page":"75568","DOI":"10.18632\/oncotarget.17369","article-title":"Cost-utility of stereotactic radiation therapy versus proton beam therapy for inoperable advanced hepatocellular carcinoma","volume":"8","author":"Leung","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0036","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12885-016-2995-5","article-title":"Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - Clinical application of health-related quality-of-life data","volume":"17","author":"Li","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0037","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jso.20374","article-title":"Quality of life in patients with hepatocellular carcinoma received surgical resection","volume":"95","author":"Lee","year":"2007","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0038","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s11136-015-0985-8","article-title":"Quality of life changes in patients undergoing treatment for hepatocellular carcinoma","volume":"24","author":"Chie","year":"2015","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ijrobp.2021.03.049_bib0039","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijrobp.2015.04.016","article-title":"Prospective longitudinal assessment of quality of life for liver cancer patients treated with stereotactic body radiation therapy","volume":"93","author":"Klein","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301621003114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301621003114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:53:02Z","timestamp":1759744382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301621003114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0360301621003114"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.03.049","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Phase 2 Study of Image-Guided Proton Therapy for Operable or Ablation-Treatable Primary Hepatocellular Carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.03.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}